Holen Sie sich die Stockscreener-App
436.56
1.66%
-5.8022
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$442.36
Offen:
$435.78
24-Stunden-Volumen:
664.54K
Relative Volume:
0.25
Marktkapitalisierung:
$235.63B
Einnahmen:
$37.30B
Nettoeinkommen (Verlust:
$7.80B
KGV:
30.36
EPS:
14.3793
Netto-Cashflow:
$8.60B
1W Leistung:
+4.11%
1M Leistung:
+19.45%
6M Leistung:
+16.08%
1J Leistung:
+46.74%
1-Tages-Spanne:
$431.46
$438.29
1-Wochen-Bereich:
$410.40
$443.20
52-Wochen-Spanne:
$269.77
$443.20
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
435.55 | 239.32B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,270.67 | 1.14T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
271.65 | 658.89B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
264.96 | 470.00B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
152.04 | 375.50B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
158.07 | 304.70B | 54.66B | 13.58B | 16.05B | 7.0171 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Hold |
| 2026-03-10 | Eingeleitet | Jefferies | Hold |
| 2026-02-20 | Eingeleitet | Barclays | Equal Weight |
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Better Bet Than Amgen Stock: INCY, NBIX Deliver More - Trefis
NewEdge Wealth LLC Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Main Street Financial Solutions LLC Takes $1.66 Million Position in Amgen Inc. $AMGN - MarketBeat
Wealthfront Advisers LLC Sells 6,410 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Danske Bank A S - MarketBeat
First National Bank of Omaha Has $15.65 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) Shares Surge 4.0% -- What GF Score of 79 Tells Investors - GuruFocus
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy - Fierce Biotech
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? - 24/7 Wall St.
Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know - TradingKey
Amgen Stock Surges 3.5% as Healthcare Hits Record High - Yahoo Finance
Amgen cans its TScan partnership; Amylyx reveals $350M offering - Endpoints News
Argus Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Amgen Inc. $AMGN Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Trust Co. of Vermont Purchases New Position in Amgen Inc. $AMGN - MarketBeat
ETFs Investing in Amgen Inc. Stocks - TradingView
Pharma in hackers' crosshairs as Amgen breach moves to courts - The Pharma Letter
Commerzbank Aktiengesellschaft FI Acquires 14,693 Shares of Amgen Inc. $AMGN - MarketBeat
AMG National Trust Bank Has $3.57 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock extends 2026 rally as Q2 earnings beat and guidance lifted - Ad-hoc-news.de
ANTITRUST NEWS—4th Cir.: FTC: Amgen’s Enbrel patent-application deal is subject to antitrust scrutiny - vitallaw.com
TScan TherapeuticsAmgen To Terminate Research Collaboration And License Agreement With TScan TherapeuticsSEC Filing - TradingView
TScan (NASDAQ: TCRX) loses Amgen Crohn’s collaboration - Stock Titan
Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Can Amgen (NASDAQ:AMGN) Extend Its Record-High Momentum? - Kalkine Media
Amgen (NASDAQ:AMGN) Results Put Growth Back In Focus - Kalkine Media
The Bull Case For Amgen (AMGN) Could Change Following Raised 2026 Earnings Guidance And Q2 BeatLearn Why - simplywall.st
Cantor Fitzgerald raises Amgen stock price target on core portfolio strength - Investing.com India
Amgen (NASDAQ:AMGN) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
Amgen stock hits all-time high at 422.49 USD - Investing.com
Amgen stock hits all-time high at 422.49 USD By Investing.com - Investing.com India
Resilient Amgen stock trades above $419 as earnings beat and 2026 guidance support momentum - AD HOC NEWS
Amgen (NASDAQ:AMGN) Given New $352.00 Price Target at Mizuho - MarketBeat
Cantor Fitzgerald Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
AMGN Maintains by Cantor Fitzgerald -- Price Target Raised to $4 - GuruFocus
Wilkinson Global Asset Management LLC Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Russell Investments Group Ltd. Sells 37,910 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Kinsale Capital Group Inc. - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Purchases 5,903 Shares of Amgen Inc. $AMGN - MarketBeat
Kelleher Financial Advisors Buys 2,580 Shares of Amgen Inc. $AMGN - MarketBeat
Jessica Merrill: Mid-Cap Biopharma's $1B-Plus Deal Surge Could Spawn the Next Amgen - finance.biggo.com
Global Retirement Partners LLC Takes $8.88 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds above $415 as Q2 2026 growth and guidance support valuation - AD HOC NEWS
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Mizuho Securities Adjusts Amgen Price Target to $352 From $303 - marketscreener.com
Amgen stock holds firm after Q2 sales raised the bar - ad-hoc-news.de
AMGN DCF Analysis: Intrinsic Value $296 vs Price $415 - GuruFocus
KBC Group NV Acquires 130,497 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Janney Montgomery Scott LLC - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amgen Inc-Aktie (AMGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Khosla Rachna | SVP, Business Development |
Aug 11 '26 |
Sale |
412.57 |
2,000 |
825,134 |
6,404 |
| Khosla Rachna | SVP, Business Development |
Aug 13 '26 |
Sale |
416.43 |
1,252 |
521,365 |
6,404 |
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):